αKLOTHO and sTGFβR2 treatment counteract the osteoarthritic phenotype developed in a rat model

Protein Cell. 2020 Mar;11(3):219-226. doi: 10.1007/s13238-019-00685-7.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cartilage, Articular / drug effects*
  • Cartilage, Articular / pathology
  • Cell Culture Techniques
  • Chondrocytes / drug effects*
  • Chondrocytes / pathology
  • Glucuronidase / therapeutic use*
  • Humans
  • Osteoarthritis, Knee / chemically induced
  • Osteoarthritis, Knee / drug therapy*
  • Papain
  • Rats
  • Receptor, Transforming Growth Factor-beta Type II / therapeutic use*
  • Recombinant Proteins / therapeutic use

Substances

  • Recombinant Proteins
  • Receptor, Transforming Growth Factor-beta Type II
  • Glucuronidase
  • klotho protein
  • Papain